Accordant Advisory Group’s Zoetis ZTS Stock Holding History

Accordant Advisory Group’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-32	Closed	-$5.42K	–	231
2024 Q1	$5.42K	Buy	+32	New	+$5.99K	﹤0.01%	182

Other funds holding ZTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Accordant Advisory Group's ZTS Position: Q2 2024 in Review

Accordant Advisory Group sold out of Zoetis (ZTS) in Q2 2024, closing a stake of 32 shares — an estimated $5.42K sold.

Accordant Advisory Group first reported a position in ZTS in Q1 2024 and held it in 1 quarter. The position peaked at $5.42K in Q1 2024. 1,733 funds tracked by Wall St. Rank hold ZTS as of Q2 2024.

Accordant Advisory Group reported no remaining Zoetis position as of Q2 2024 after selling out during the quarter.
Accordant Advisory Group sold 32 Zoetis shares in Q2 2024, an estimated $5.42K.
Accordant Advisory Group first reported a position in Zoetis in Q1 2024 and held it in 1 quarter.
Accordant Advisory Group's Zoetis position peaked at $5.42K in Q1 2024.
1,733 funds tracked by Wall St. Rank held Zoetis as of Q2 2024.

Based on Accordant Advisory Group's 13F filing for Q2 2024, filed 19 Jul 2024.